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Abstract
Background: Clinical laboratories accredited accord-
ing to ISO 15189 quality standards are obliged to
implement and continuously monitor quality indica-
tors for evaluation of the laboratory’s contribution to
patient care. Reporting laboratory results to the
requesting physician is one important phase of the
clinical laboratory testing process. Failure to report
results may indicate the ineffectiveness of the labo-
ratory service. We aimed to analyze the proportion
and type of laboratory reports for outpatients that
were not delivered to the requesting physician.
Methods: This retrospective observational study was
conducted during an 11-month period from January
to December 2007 at our outpatient biochemistry
laboratory unit. Data on demographic characteristics,
request types and laboratory findings for all uncollect-
ed reports were retrieved from the laboratory
information system and compared with one random
2-week representative period.
Results: During the study period our laboratory
issued 22,445 patient reports with more than 150,000
biochemistry analyses. Of these, 464 (2.1%) were
uncollected laboratory reports. When compared to
the representative period, patients who never collect-
ed their laboratory reports were younger (p-0.001)
or suffering from some chronic disease. Routine bio-
chemistry tests were the most prevalent ()50%). The
majority of routine biochemistry tests were almost
equally represented during the study and represen-
tative period, while molecular diagnostic tests were
several times more frequently uncollected (p-0.001).
Reports with electrolytes, metabolites and glucose
were the least likely to be uncollected (p-0.001). The
total cost for those tests was 30% of the average
monthly laboratory budget.
Conclusions: A significant amount of the laboratory
budget is wasted for tests that never reach the
requesting physician. Such misutilization of the lab-
oratory reveals the substantial lack of medical neces-
sity for test requests. Further studies are needed to
explore the possible efficiency of the various inter-
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ventions in reducing the volume of unnecessary and
erroneous testing.
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Introduction
Clinical laboratories accredited according to ISO
15189 quality standard are obliged to implement and
continuously monitor quality indicators for evaluation
of the laboratory’s contribution to patient care. Qual-
ity indicators can either be measures of processes,
outcomes or contribution of the laboratory to patient
care (1–3). It is crucial that quality indicators address
all three key processes in the laboratory: preanalyti-
cal, analytical and postanalytical (1, 4). Reporting lab-
oratory results to the requesting physician is one
important phase of the clinical laboratory testing
process. Failure to notify the physician of test results
may indicate the ineffectiveness of the laboratory
service. Results never reported to the physician affect
the quality of patient care and unnecessarily waste
financial health resources. Computerized automated
communication may significantly improve the effec-
tiveness and timeliness of laboratory report notifica-
tion in large clinical laboratories (5). However, it does
not solve the issue of unjustified or unnecessary
requests. Furthermore, the efficiency of timely deliv-
ery of test reports to the requesting physician in an
outpatient setting is questionable. We analyzed the
proportion and type of laboratory reports for out-
patients that were never delivered to the requesting
physician. To the best of our knowledge, such a sur-
vey has not been performed or reported in the
literature.
Materials and methods
Setting
This retrospective observational study was conducted during
an 11-month period from January to December 2007 at an
outpatient biochemistry laboratory unit of the University
Department of Chemistry at the University hospital ‘‘Sestre
milosrdnice’’, in Zagreb, Croatia. Our hospital is a 900-bed
tertiary care University hospital. The laboratory is accredited
according to ISO 15189 standard and performs up to three
million tests per year with a following test panel: routine
general biochemistry, urine analysis, protein analysis, auto-
immune disease testing, neurobiochemistry, toxicology,
molecular diagnostics, hematology and coagulation. On
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Table 1 Patient demographic data and total cost for uncollected reports and the 2-week representative period.
Parameters Representative period Uncollected reports p-Value
ns1122 ns464
Male gender, n (%) 392 (34.9) 174 (37.5) 0.362a
Age, years 58 (43–69) 53 (35–66) 0.001b
Living in Zagreb, n (%) 758 (67.6) 299 (64.4) 0.012a
Total cost, 7 17.22 (7.13–37.77) 23.99 (8.42–50.92) 0.001b
Patient co-pay, 7 0.49 (0–3.10) 0 (0–3.63) 0.102b
ax2-test; bMann-Whitney test.
average, there are 80 outpatients per day in our laboratory.
Upon completion, a hard copy outpatient test report is col-
lected by the patient. For the majority of test parameters, the
turn-around time (TAT) is 1 working day. For autoimmune
disease testing and molecular diagnostics, the TAT may be
up to 4 weeks. Since the hematology and coagulation out-
patient unit is not located in our central laboratory, we
excluded their reports from this analysis.
Data retrieval
We analyzed data on demographic characteristics, request
types and laboratory findings for all uncollected reports in
the study period. Laboratory reports were considered uncol-
lected if not collected within 3 months after being issued. In
order to compare parameters of the uncollected reports with
what is considered average, we chose one random 2-week
representative period for comparison. The following demo-
graphic data were collected: patient age, gender, diagnosis,
residence (people living in Zagreb vs. those living outside
Zagreb), cost for requested analyses as refunded by the
health insurance company and the amount co-payment paid
by the patient. Depending on the type of insurance, patients
may have 0%–100% coverage from the insurer. Laboratory
findings were categorized as (i) within the reference interval,
(ii) borderline, and (iii) outside the reference interval. Bor-
derline results were considered as those exceeding the low-
er/upper reference value by -5%. Data needed for analysis
were retrieved from our laboratory information system.
Statistical analysis
Distribution of each continuous quantitative variable was
assessed for normality using the Kolmogorov-Smirnov test.
Descriptive categorical data were presented as numbers
(counts) and percentages. Continuous quantitative variables
showed deviation from normality and were, therefore, pre-
sented as medians and interquartile ranges. Differences
between observed proportions were tested with the x2 and
z-test. Differences between continuous variables were tested
with the non-parametric Mann-Whitney test. The level of sig-
nificance was set at 0.05. Statistical analysis was performed
using MedCalc statistical software (MedCalc 10.1.3.1, Frank
Schoonjans, Mariakerke, Belgium).
Results
There were a total of 22,445 patient reports with more
than 150,000 biochemistry analyses tested during this
11-month survey. Of this total, we registered 464
(2.1%) uncollected laboratory reports (1569 analyses).
The total cost for analyses for the reports that were
never collected was 30% of the average monthly
laboratory budget. There were 1122 reports (11,834
analyses) during the representative period. Patient
demographic data and cost of the analyses for uncol-
lected reports and the representative period are
shown in Table 1.
When compared to the representative period,
patients who never collected their laboratory reports
were younger (p-0.001). The average total cost for
uncollected test reports was 40% higher (ps0.001). Of
those who never collected their reports, more patients
lived outside Zagreb.
There were 36% of patients in the age group of
19–50 years who did not collect their reports, as
opposed to 25% in the representative period. Older
patients ()70 years) were more likely to collect their
reports (ps0.009), as shown in Table 2.
For those who did not collect their reports, the
majority of laboratory findings were within the refer-
ence interval, while only one-third of the patient find-
ings were borderline or outside the reference interval
(Table 3).
In order to explore whether patients with certain
diagnoses collect their reports, we tested for possible
differences between proportions of diagnoses during
the two study periods. Diagnoses were equally rep-
resented within the two study groups (data not pre-
sented). Patients who did not collect their laboratory
reports during both study periods were more likely to
be individuals suffering from some chronic disease.
Almost 60% of these were patients with diabetes mel-
litus, thyroid disease, iron deficiency anemia or osteo-
porosis. The only modest difference observed was in
the proportion of thyroid disease among studied
periods. There were 9.0% and 4.8% of patients with
chronic thyroid disease among the uncollected
reports group and representative period, respectively
(ps0.050).
To assess whether reports with certain analyses are
collected more often, we tested the possible differ-
ence between types of analyses during the two study
periods. Routine biochemistry tests were the most
prevalent ()50%). The majority of routine biochem-
istry tests were almost equally represented during the
study and representative periods. However, some
more expensive analyses such as molecular diagnos-
tic tests were several times more frequently uncollect-
ed (p-0.001). Reports with electrolytes, metabolites
and glucose were the least likely to be uncollected
(p-0.001) (Table 4).
Discussion
There is a growing need to introduce measurable and
evidence based indicators of laboratory efficiency and
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Table 2 Patient age distribution for uncollected reports
(ns440) and representative period (ns1112).
Age, years Representative Uncollected p-Valuea
period, n (%) reports, n (%)
F18 108 (9.7) 37 (8.4) 0.486
19–30 69 (6.2) 52 (11.8) -0.001
31–50 212 (19.1) 106 (24.1) 0.032
51–70 498 (44.8) 182 (41.4) 0.243
)70 225 (20.2) 63 (14.3) 0.009
aMann-Whitney test.
Table 3 Laboratory findings for patients who never collect-
ed their reports (ns464).
Laboratory findings n (%)
Borderline 28 (6.0)
Within reference interval 305 (65.7)
Outside reference interval 131 (28.2)
Table 4 Difference between uncollected and collected test results relative to the test panel groups during the studied period
of 11 months.
Test panel Representative period, Uncollected reports, p-Valuea OR (95% CI)
(total number of (total number of
analysess11,834), n (%) analysess1569), n (%)
Molecular diagnostics 48 (0.41) 50 (3.19) -0.001 7.86 (5.26–11.72)
Toxicology 18 (0.15) 14 (0.89) -0.001 5.87 (2.91–11.82)
Vitamins 42 (0.35) 20 (1.27) -0.001 3.59 (2.10–6.13)
Immunology 243 (2.05) 107 (6.82) -0.001 3.32 (2.63–4.19)
Autoimmune disease testing 408 (3.45) 121 (7.71) -0.001 2.24 (1.82–2.76)
Occult blood test 26 (0.22) 7 (0.45) 0.097 2.03 (0.88–4.69)
Proteins 793 (6.70) 146 (9.31) -0.001 1.39 (1.16–1.67)
Therapeutic drug monitoring 76 (0.64) 11 (0.70) 0.787 1.09 (0.58–2.06)
Trace elements 909 (7.68) 123 (7.84) 0.838 1.02 (0.84–1.24)
Lipids and lipoproteins 1377 (11.64) 191 (12.17) 0.581 1.05 (0.89–1.23)
Enzymes 2095 (17.70) 266 (16.95) 0.539 0.96 (0.83–1.10)
Electrophoresis 238 (2.01) 29 (1.85) 0.671 0.92 (0.62–1.36)
Bone markers 198 (1.67) 24 (1.53) 0.681 0.91 (0.60–1.40)
Urinalysis 218 (1.84) 25 (1.59) 0.496 0.87 (0.57–1.31)
Metabolites 2039 (17.23) 193 (12.30) -0.001 0.71 (0.61–0.84)
Electrolytes 2176 (18.39) 190 (12.11) -0.001 0.66 (0.56–0.77)
Glucose metabolism 850 (7.18) 51 (3.25) -0.001 0.45 (0.34–0.60)
Blood gas testing 80 (0.68) 1 (0.06) 0.019 0.09 (0.01–0.68)
aZ-test. OR, odds ratio; CI, confidence interval.
its contribution to clinical effectiveness into every
segment of the health care system (6–8). Erroneous
and unnecessary test requests surely increase health
care expenditure and reduce the quality of patient
care. Quality of patient care is endangered by both
unnecessary phlebotomy which might lead to iatro-
genic anemia (9), and by failing to provide adequate
care to the patient.
Our aim was to analyze the volume and the total
cost of laboratory reports never seen by the request-
ing physician. The key finding of this study is that a
significant amount of the laboratory budget is wasted
for tests that never reach the requesting physician. In
our opinion, such misutilization of the laboratory
surely demonstrates the substantial lack of medical
necessity for test requests.
Quite interestingly, middle aged patients whose
biochemical parameters were within the reference
interval and who were suffering from some chronic
disease were more likely not to collect their reports
when compared to children, teenagers or older indi-
viduals. The possible explanation could be that the
requesting physician ordered unnecessary tests for
those patients. Inappropriate use of the laboratory
has been widely documented in clinical practice
(10–12).
Although the majority of uncollected reports were
those for routine biochemistry tests, it is quite a para-
dox that reports for highly specialized and more
expensive tests were more likely to be uncollected.
For example, molecular diagnostic panels for inherit-
ed thrombophilia risk screening, which accounted for
only 3% of all uncollected reports, had the highest
probability to be uncollected. The possible explana-
tion for this might be that these tests have longer
TATs. Thus, patients could easily forget that there are
some reports missing after waiting for 3–4 weeks.
Patients who suffer from some chronic disease and
are referred from their primary care physician for
some additional or regular periodic diagnostic work-
up might not be highly motivated to collect their
laboratory findings. It is possible that they cannot
foresee the direct benefit of the testing. On the other
hand, patients having an acute condition and requir-
ing some action from their physician are probably
more motivated to collect their reports.
One very interesting question is why does not a
requesting physician request the results himself or
stimulate his patient to get them? Specific proteins,
vitamins, autoimmune disease markers and molecu-
lar diagnostic tests are certainly not routine but rather
expensive laboratory tests. The requesting physician
is supposed to have a sound knowledge that such
tests exist, but also understand the rationale of the
test itself. In that respect, it is difficult to believe that
physicians are not interested in test results. The rea-
son why the physician is not stimulating the patient
to collect the test report is yet to be explored.
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Many attempts have been made with the aim of
improving the appropriateness of test requesting
behavior, as well as reducing the testing volume
(13–15). Continuous education of medical doctors has
been demonstrated as an effective means for decreas-
ing redundant tests ordering in the hospital setting
(16) as well as by practicing community physicians
(17).
The authors of this work agree that educational
intervention might be, to some extent, effective in
reducing the volume of unnecessary testing. This
hypothesis should, however, be properly tested in the
appropriate clinical setting.
The other issue is the delivery mode for test
reports. In our country, it is the responsibility of the
patient to collect his or her report. If the test was not
needed in the first place, or the time interval needed
to issue the report is too long, the laboratory report
is more likely not to be collected. Implementing elec-
tronic delivery systems of laboratory reports to the
requesting physician might be a way to improve the
effectiveness of patient care. There is strong evidence
on the effectiveness of systems for electronic request
and delivery of test reports in terms of improving
health care in primary care practices (18).
Based on our results, we conclude that a significant
amount of the laboratory budget is wasted for tests
that never reach the requesting primary care physi-
cian. Further studies are needed to explore the
possible efficiency of the various interventions in
reducing the volume of unnecessary and erroneous
testing.
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